GLB1 and cancer: However, the remaining eight cancer-specific DESPGs of GLB1, HSPA5, PDIA3, GNRH1, IFNGR2 ADAM9, TPST2, and TAC4) were not reported in any researches, which could be potential novel prognostic biomarkers in corresponding tumors.